Skip to main content
Top
Published in: Angiogenesis 4/2014

01-10-2014 | Original Paper

Acidic preconditioning improves the proangiogenic responses of endothelial colony forming cells

Authors: Hebe A. Mena, Anna Lokajczyk, Blandine Dizier, Sergio E. Strier, Liliana S. Voto, Catherine Boisson-Vidal, Mirta Schattner, Soledad Negrotto

Published in: Angiogenesis | Issue 4/2014

Login to get access

Abstract

Objective

Acidosis is present in several pathological conditions where vasculogenesis takes place including ischemia, tumor growth and wound healing. We have previously demonstrated that acidosis induces human CD34+ cell apoptosis. Considering that endothelial colony-forming cells (ECFC) are a subpopulation of CD34+ cells and key players in vasculogenesis, in the present study we investigated the effect of acidosis on the survival and functionality of ECFC.

Approach and results

Endothelial colony-forming cells obtained by differentiation of human cord blood CD34+ cells in endothelial growth medium-2 for 14–21 days were exposed at pH 7.4, 7.0 or 6.6. We found that acidosis failed to induce ECFC apoptosis and, although an early reduction in proliferation, chemotaxis, wound healing and capillary-like tubule formation was observed, once the medium pH was restored to 7.4, ECFC proliferation and tubulogenesis were augmented. Stromal cell derived factor-1 (SDF1)-driven migration and chemokine receptor type 4 surface expression were also increased. The maximal proangiogenic effect exerted by acidic preconditioning was observed after 6 h at pH 6.6. Furthermore, preconditioned ECFC showed an increased ability to promote tissue revascularization in a murine model of hind limb ischemia. Immunoblotting assays showed that acidosis activated AKT and ERK1/2 and inhibited p38 pathways. Proliferation rises triggered by acidic preconditioning were no longer observed after AKT or ERK1/2 inhibition, whereas p38 suppression not only mimicked but also potentiated the effect of acidosis on ECFC tubule formation abilities.

Conclusions

These results demonstrate that acidic preconditioning greatly increases ECFC-mediated angiogenesis in vitro including ECFC proliferation, tubulogenesis and SDF1-driven chemotaxis and is a positive regulator of microvessel formation in vivo.
Literature
3.
go back to reference Assmus B, Schachinger V, Teupe C, Britten M, Lehmann R, Dobert N, Grunwald F, Aicher A, Urbich C, Martin H, Hoelzer D, Dimmeler S, Zeiher AM (2002) Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI). Circulation 106:3009–3017PubMedCrossRef Assmus B, Schachinger V, Teupe C, Britten M, Lehmann R, Dobert N, Grunwald F, Aicher A, Urbich C, Martin H, Hoelzer D, Dimmeler S, Zeiher AM (2002) Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI). Circulation 106:3009–3017PubMedCrossRef
4.
go back to reference Sinha S, Poh KK, Sodano D, Flanagan J, Ouilette C, Kearney M, Heyd L, Wollins J, Losordo D, Weinstein R (2006) Safety and efficacy of peripheral blood progenitor cell mobilization and collection in patients with advanced coronary heart disease. J Clin Apher 21:116–120PubMedCrossRef Sinha S, Poh KK, Sodano D, Flanagan J, Ouilette C, Kearney M, Heyd L, Wollins J, Losordo D, Weinstein R (2006) Safety and efficacy of peripheral blood progenitor cell mobilization and collection in patients with advanced coronary heart disease. J Clin Apher 21:116–120PubMedCrossRef
5.
go back to reference Fadini GP, Avogaro A (2010) Potential manipulation of endothelial progenitor cells in diabetes and its complications. Diabetes Obes Metab 12:570–583PubMedCrossRef Fadini GP, Avogaro A (2010) Potential manipulation of endothelial progenitor cells in diabetes and its complications. Diabetes Obes Metab 12:570–583PubMedCrossRef
6.
go back to reference Werner N, Priller J, Laufs U, Endres M, Bohm M, Dirnagl U, Nickenig G (2002) Bone marrow-derived progenitor cells modulate vascular reendothelialization and neointimal formation: effect of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition. Arterioscler Thromb Vasc Biol 22:1567–1572PubMedCrossRef Werner N, Priller J, Laufs U, Endres M, Bohm M, Dirnagl U, Nickenig G (2002) Bone marrow-derived progenitor cells modulate vascular reendothelialization and neointimal formation: effect of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition. Arterioscler Thromb Vasc Biol 22:1567–1572PubMedCrossRef
7.
go back to reference Raval Z, Losordo DW (2013) Cell therapy of peripheral arterial disease: from experimental findings to clinical trials. Circ Res 112:1288–1302PubMedCrossRef Raval Z, Losordo DW (2013) Cell therapy of peripheral arterial disease: from experimental findings to clinical trials. Circ Res 112:1288–1302PubMedCrossRef
8.
go back to reference Trevani AS, Andonegui G, Giordano M, Lopez DH, Gamberale R, Minucci F, Geffner JR (1999) Extracellular acidification induces human neutrophil activation. J Immunol 162:4849–4857PubMed Trevani AS, Andonegui G, Giordano M, Lopez DH, Gamberale R, Minucci F, Geffner JR (1999) Extracellular acidification induces human neutrophil activation. J Immunol 162:4849–4857PubMed
9.
go back to reference Serrano CV Jr, Fraticelli A, Paniccia R, Teti A, Noble B, Corda S, Faraggiana T, Ziegelstein RC, Zweier JL, Capogrossi MC (1996) pH dependence of neutrophil-endothelial cell adhesion and adhesion molecule expression. Am J Physiol 271:C962–C970PubMed Serrano CV Jr, Fraticelli A, Paniccia R, Teti A, Noble B, Corda S, Faraggiana T, Ziegelstein RC, Zweier JL, Capogrossi MC (1996) pH dependence of neutrophil-endothelial cell adhesion and adhesion molecule expression. Am J Physiol 271:C962–C970PubMed
10.
go back to reference Martinez D, Vermeulen M, von Euw E, Sabatte J, Maggini J, Ceballos A, Trevani A, Nahmod K, Salamone G, Barrio M, Giordano M, Amigorena S, Geffner J (2007) Extracellular acidosis triggers the maturation of human dendritic cells and the production of IL-12. J Immunol 179:1950–1959PubMedCrossRef Martinez D, Vermeulen M, von Euw E, Sabatte J, Maggini J, Ceballos A, Trevani A, Nahmod K, Salamone G, Barrio M, Giordano M, Amigorena S, Geffner J (2007) Extracellular acidosis triggers the maturation of human dendritic cells and the production of IL-12. J Immunol 179:1950–1959PubMedCrossRef
11.
go back to reference DeClerck K, Elble RC (2010) The role of hypoxia and acidosis in promoting metastasis and resistance to chemotherapy. Front Biosci (Landmark Ed) 15:213–225CrossRef DeClerck K, Elble RC (2010) The role of hypoxia and acidosis in promoting metastasis and resistance to chemotherapy. Front Biosci (Landmark Ed) 15:213–225CrossRef
12.
go back to reference Huang Y, McNamara JO (2004) Ischemic stroke: “acidotoxicity” is a perpetrator. Cell 118:665–666PubMedCrossRef Huang Y, McNamara JO (2004) Ischemic stroke: “acidotoxicity” is a perpetrator. Cell 118:665–666PubMedCrossRef
13.
14.
go back to reference Cronberg T, Rytter A, Asztely F, Soder A, Wieloch T (2004) Glucose but not lactate in combination with acidosis aggravates ischemic neuronal death in vitro. Stroke 35:753–757PubMedCrossRef Cronberg T, Rytter A, Asztely F, Soder A, Wieloch T (2004) Glucose but not lactate in combination with acidosis aggravates ischemic neuronal death in vitro. Stroke 35:753–757PubMedCrossRef
15.
go back to reference Smith ML, von Hanwehr R, Siesjo BK (1986) Changes in extra- and intracellular pH in the brain during and following ischemia in hyperglycemic and in moderately hypoglycemic rats. J Cereb Blood Flow Metab 6:574–583PubMedCrossRef Smith ML, von Hanwehr R, Siesjo BK (1986) Changes in extra- and intracellular pH in the brain during and following ischemia in hyperglycemic and in moderately hypoglycemic rats. J Cereb Blood Flow Metab 6:574–583PubMedCrossRef
16.
go back to reference D’Atri LP, Etulain J, Romaniuk MA, Torres O, Negrotto S, Schattner M (2011) The low viability of human CD34+ cells under acidic conditions is improved by exposure to thrombopoietin, stem cell factor, interleukin-3, or increased cyclic adenosine monophosphate levels. Transfusion 51:1784–1795PubMedCrossRef D’Atri LP, Etulain J, Romaniuk MA, Torres O, Negrotto S, Schattner M (2011) The low viability of human CD34+ cells under acidic conditions is improved by exposure to thrombopoietin, stem cell factor, interleukin-3, or increased cyclic adenosine monophosphate levels. Transfusion 51:1784–1795PubMedCrossRef
17.
go back to reference Zemani F, Benisvy D, Galy-Fauroux I, Lokajczyk A, Colliec-Jouault S, Uzan G, Fischer AM, Boisson-Vidal C (2005) Low-molecular-weight fucoidan enhances the proangiogenic phenotype of endothelial progenitor cells. Biochem Pharmacol 70:1167–1175PubMedCrossRef Zemani F, Benisvy D, Galy-Fauroux I, Lokajczyk A, Colliec-Jouault S, Uzan G, Fischer AM, Boisson-Vidal C (2005) Low-molecular-weight fucoidan enhances the proangiogenic phenotype of endothelial progenitor cells. Biochem Pharmacol 70:1167–1175PubMedCrossRef
18.
go back to reference Benslimane-Ahmim Z, Heymann D, Dizier B, Lokajczyk A, Brion R, Laurendeau I, Bieche I, Smadja DM, Galy-Fauroux I, Colliec-Jouault S, Fischer AM, Boisson-Vidal C (2011) Osteoprotegerin, a new actor in vasculogenesis, stimulates endothelial colony-forming cells properties. J Thromb Haemost 9:834–843PubMedCrossRef Benslimane-Ahmim Z, Heymann D, Dizier B, Lokajczyk A, Brion R, Laurendeau I, Bieche I, Smadja DM, Galy-Fauroux I, Colliec-Jouault S, Fischer AM, Boisson-Vidal C (2011) Osteoprotegerin, a new actor in vasculogenesis, stimulates endothelial colony-forming cells properties. J Thromb Haemost 9:834–843PubMedCrossRef
19.
go back to reference Zemani F, Silvestre JS, Fauvel-Lafeve F, Bruel A, Vilar J, Bieche I, Laurendeau I, Galy-Fauroux I, Fischer AM, Boisson-Vidal C (2008) Ex vivo priming of endothelial progenitor cells with SDF-1 before transplantation could increase their proangiogenic potential. Arterioscler Thromb Vasc Biol 28:644–650PubMedCrossRef Zemani F, Silvestre JS, Fauvel-Lafeve F, Bruel A, Vilar J, Bieche I, Laurendeau I, Galy-Fauroux I, Fischer AM, Boisson-Vidal C (2008) Ex vivo priming of endothelial progenitor cells with SDF-1 before transplantation could increase their proangiogenic potential. Arterioscler Thromb Vasc Biol 28:644–650PubMedCrossRef
20.
go back to reference Benslimane-Ahmim Z, Poirier F, Delomenie C, Lokajczyk A, Grelac F, Galy-Fauroux I, Mohamedi A, Fischer AM, Heymann D, Lutomski D, Boisson-Vidal C (2013) Mechanistic study of the proangiogenic effect of osteoprotegerin. Angiogenesis 16:575–593PubMedCrossRef Benslimane-Ahmim Z, Poirier F, Delomenie C, Lokajczyk A, Grelac F, Galy-Fauroux I, Mohamedi A, Fischer AM, Heymann D, Lutomski D, Boisson-Vidal C (2013) Mechanistic study of the proangiogenic effect of osteoprotegerin. Angiogenesis 16:575–593PubMedCrossRef
21.
go back to reference Della Bella S, Taddeo A, Calabro ML, Brambilla L, Bellinvia M, Bergamo E, Clerici M, Villa ML (2008) Peripheral blood endothelial progenitors as potential reservoirs of Kaposi’s sarcoma-associated herpesvirus. PLoS One 3:e1520PubMedCrossRefPubMedCentral Della Bella S, Taddeo A, Calabro ML, Brambilla L, Bellinvia M, Bergamo E, Clerici M, Villa ML (2008) Peripheral blood endothelial progenitors as potential reservoirs of Kaposi’s sarcoma-associated herpesvirus. PLoS One 3:e1520PubMedCrossRefPubMedCentral
22.
go back to reference Negrotto S, Pacienza N, D’Atri LP, Pozner RG, Malaver E, Torres O, Lazzari MA, Gomez RM, Schattner M (2006) Activation of cyclic AMP pathway prevents CD34(+) cell apoptosis. Exp Hematol 34:1420–1428PubMedCrossRef Negrotto S, Pacienza N, D’Atri LP, Pozner RG, Malaver E, Torres O, Lazzari MA, Gomez RM, Schattner M (2006) Activation of cyclic AMP pathway prevents CD34(+) cell apoptosis. Exp Hematol 34:1420–1428PubMedCrossRef
23.
go back to reference Foubert P, Silvestre JS, Souttou B, Barateau V, Martin C, Ebrahimian TG, Lere-Dean C, Contreres JO, Sulpice E, Levy BI, Plouet J, Tobelem G, Le Ricousse-Roussanne S (2007) PSGL-1-mediated activation of EphB4 increases the proangiogenic potential of endothelial progenitor cells. J Clin Invest 117:1527–1537PubMedCrossRefPubMedCentral Foubert P, Silvestre JS, Souttou B, Barateau V, Martin C, Ebrahimian TG, Lere-Dean C, Contreres JO, Sulpice E, Levy BI, Plouet J, Tobelem G, Le Ricousse-Roussanne S (2007) PSGL-1-mediated activation of EphB4 increases the proangiogenic potential of endothelial progenitor cells. J Clin Invest 117:1527–1537PubMedCrossRefPubMedCentral
24.
go back to reference Sarlon G, Zemani F, David L, Duong Van Huyen JP, Dizier B, Grelac F, Colliec-Jouault S, Galy-Fauroux I, Bruneval P, Fischer AM, Emmerich J, Boisson-Vidal C (2012) Therapeutic effect of fucoidan-stimulated endothelial colony-forming cells in peripheral ischemia. J Thromb Haemost 10:38–48PubMedCrossRef Sarlon G, Zemani F, David L, Duong Van Huyen JP, Dizier B, Grelac F, Colliec-Jouault S, Galy-Fauroux I, Bruneval P, Fischer AM, Emmerich J, Boisson-Vidal C (2012) Therapeutic effect of fucoidan-stimulated endothelial colony-forming cells in peripheral ischemia. J Thromb Haemost 10:38–48PubMedCrossRef
25.
go back to reference Cencioni C, Capogrossi MC, Napolitano M (2012) The SDF-1/CXCR4 axis in stem cell preconditioning. Cardiovasc Res 94:400–407PubMedCrossRef Cencioni C, Capogrossi MC, Napolitano M (2012) The SDF-1/CXCR4 axis in stem cell preconditioning. Cardiovasc Res 94:400–407PubMedCrossRef
26.
go back to reference Yoder MC, Mead LE, Prater D, Krier TR, Mroueh KN, Li F, Krasich R, Temm CJ, Prchal JT, Ingram DA (2007) Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood 109:1801–1809PubMedCrossRefPubMedCentral Yoder MC, Mead LE, Prater D, Krier TR, Mroueh KN, Li F, Krasich R, Temm CJ, Prchal JT, Ingram DA (2007) Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood 109:1801–1809PubMedCrossRefPubMedCentral
27.
go back to reference Au P, Daheron LM, Duda DG, Cohen KS, Tyrrell JA, Lanning RM, Fukumura D, Scadden DT, Jain RK (2008) Differential in vivo potential of endothelial progenitor cells from human umbilical cord blood and adult peripheral blood to form functional long-lasting vessels. Blood 111:1302–1305PubMedCrossRefPubMedCentral Au P, Daheron LM, Duda DG, Cohen KS, Tyrrell JA, Lanning RM, Fukumura D, Scadden DT, Jain RK (2008) Differential in vivo potential of endothelial progenitor cells from human umbilical cord blood and adult peripheral blood to form functional long-lasting vessels. Blood 111:1302–1305PubMedCrossRefPubMedCentral
28.
go back to reference Cross MJ, Claesson-Welsh L (2001) FGF and VEGF function in angiogenesis: signalling pathways, biological responses and therapeutic inhibition. Trends Pharmacol Sci 22:201–207PubMedCrossRef Cross MJ, Claesson-Welsh L (2001) FGF and VEGF function in angiogenesis: signalling pathways, biological responses and therapeutic inhibition. Trends Pharmacol Sci 22:201–207PubMedCrossRef
29.
go back to reference Morello F, Perino A, Hirsch E (2009) Phosphoinositide 3-kinase signalling in the vascular system. Cardiovasc Res 82:261–271PubMedCrossRef Morello F, Perino A, Hirsch E (2009) Phosphoinositide 3-kinase signalling in the vascular system. Cardiovasc Res 82:261–271PubMedCrossRef
30.
go back to reference Gerwins P, Skoldenberg E, Claesson-Welsh L (2000) Function of fibroblast growth factors and vascular endothelial growth factors and their receptors in angiogenesis. Crit Rev Oncol Hematol 34:185–194PubMedCrossRef Gerwins P, Skoldenberg E, Claesson-Welsh L (2000) Function of fibroblast growth factors and vascular endothelial growth factors and their receptors in angiogenesis. Crit Rev Oncol Hematol 34:185–194PubMedCrossRef
31.
go back to reference D’Arcangelo D, Facchiano F, Barlucchi LM, Melillo G, Illi B, Testolin L, Gaetano C, Capogrossi MC (2000) Acidosis inhibits endothelial cell apoptosis and function and induces basic fibroblast growth factor and vascular endothelial growth factor expression. Circ Res 86:312–318PubMedCrossRef D’Arcangelo D, Facchiano F, Barlucchi LM, Melillo G, Illi B, Testolin L, Gaetano C, Capogrossi MC (2000) Acidosis inhibits endothelial cell apoptosis and function and induces basic fibroblast growth factor and vascular endothelial growth factor expression. Circ Res 86:312–318PubMedCrossRef
32.
go back to reference Fujita M, Asanuma H, Hirata A, Wakeno M, Takahama H, Sasaki H, Kim J, Takashima S, Tsukamoto O, Minamino T, Shinozaki Y, Tomoike H, Hori M, Kitakaze M (2007) Prolonged transient acidosis during early reperfusion contributes to the cardioprotective effects of postconditioning. Am J Physiol Heart Circ Physiol 292:H2004–H2008PubMedCrossRef Fujita M, Asanuma H, Hirata A, Wakeno M, Takahama H, Sasaki H, Kim J, Takashima S, Tsukamoto O, Minamino T, Shinozaki Y, Tomoike H, Hori M, Kitakaze M (2007) Prolonged transient acidosis during early reperfusion contributes to the cardioprotective effects of postconditioning. Am J Physiol Heart Circ Physiol 292:H2004–H2008PubMedCrossRef
33.
go back to reference Costello J, Higgins B, Contreras M, Chonghaile MN, Hassett P, O’Toole D, Laffey JG (2009) Hypercapnic acidosis attenuates shock and lung injury in early and prolonged systemic sepsis. Crit Care Med 37:2412–2420PubMedCrossRef Costello J, Higgins B, Contreras M, Chonghaile MN, Hassett P, O’Toole D, Laffey JG (2009) Hypercapnic acidosis attenuates shock and lung injury in early and prolonged systemic sepsis. Crit Care Med 37:2412–2420PubMedCrossRef
34.
go back to reference Flacke JP, Kumar S, Kostin S, Reusch HP, Ladilov Y (2009) Acidic preconditioning protects endothelial cells against apoptosis through p38- and Akt-dependent Bcl-xL overexpression. Apoptosis 14:90–96PubMedCrossRefPubMedCentral Flacke JP, Kumar S, Kostin S, Reusch HP, Ladilov Y (2009) Acidic preconditioning protects endothelial cells against apoptosis through p38- and Akt-dependent Bcl-xL overexpression. Apoptosis 14:90–96PubMedCrossRefPubMedCentral
35.
go back to reference Kumar S, Reusch HP, Ladilov Y (2008) Acidic pre-conditioning suppresses apoptosis and increases expression of Bcl-xL in coronary endothelial cells under simulated ischaemia. J Cell Mol Med 12:1584–1592PubMedCrossRef Kumar S, Reusch HP, Ladilov Y (2008) Acidic pre-conditioning suppresses apoptosis and increases expression of Bcl-xL in coronary endothelial cells under simulated ischaemia. J Cell Mol Med 12:1584–1592PubMedCrossRef
36.
go back to reference Froyland E, Skjaeret C, Wright MS, Dalen ML, Cvancarova M, Kasi C, Rootwelt T (2008) Inflammatory receptors and pathways in human NT2-N neurons during hypoxia and reoxygenation. Impact of acidosis. Brain Res 1217:37–49PubMedCrossRef Froyland E, Skjaeret C, Wright MS, Dalen ML, Cvancarova M, Kasi C, Rootwelt T (2008) Inflammatory receptors and pathways in human NT2-N neurons during hypoxia and reoxygenation. Impact of acidosis. Brain Res 1217:37–49PubMedCrossRef
37.
go back to reference Cencioni C, Melchionna R, Straino S, Romani M, Cappuzzello C, Annese V, Wu JC, Pompilio G, Santoni A, Gaetano C, Napolitano M, Capogrossi MC (2011) Ex vivo acidic preconditioning enhances bone marrow ckit+ cell therapeutic potential via increased CXCR4 expression. Eur Heart J 34:2007–2016PubMedCrossRefPubMedCentral Cencioni C, Melchionna R, Straino S, Romani M, Cappuzzello C, Annese V, Wu JC, Pompilio G, Santoni A, Gaetano C, Napolitano M, Capogrossi MC (2011) Ex vivo acidic preconditioning enhances bone marrow ckit+ cell therapeutic potential via increased CXCR4 expression. Eur Heart J 34:2007–2016PubMedCrossRefPubMedCentral
38.
go back to reference Goerges AL, Nugent MA (2003) Regulation of vascular endothelial growth factor binding and activity by extracellular pH. J Biol Chem 278:19518–19525PubMedCrossRef Goerges AL, Nugent MA (2003) Regulation of vascular endothelial growth factor binding and activity by extracellular pH. J Biol Chem 278:19518–19525PubMedCrossRef
39.
go back to reference Kucia M, Jankowski K, Reca R, Wysoczynski M, Bandura L, Allendorf DJ, Zhang J, Ratajczak J, Ratajczak MZ (2004) CXCR4-SDF-1 signalling, locomotion, chemotaxis and adhesion. J Mol Histol 35:233–245PubMedCrossRef Kucia M, Jankowski K, Reca R, Wysoczynski M, Bandura L, Allendorf DJ, Zhang J, Ratajczak J, Ratajczak MZ (2004) CXCR4-SDF-1 signalling, locomotion, chemotaxis and adhesion. J Mol Histol 35:233–245PubMedCrossRef
40.
go back to reference Everaert BR, Van Craenenbroeck EM, Hoymans VY, Haine SE, Van Nassauw L, Conraads VM, Timmermans JP, Vrints CJ (2010) Current perspective of pathophysiological and interventional effects on endothelial progenitor cell biology: focus on PI3K/AKT/eNOS pathway. Int J Cardiol 144:350–366PubMedCrossRef Everaert BR, Van Craenenbroeck EM, Hoymans VY, Haine SE, Van Nassauw L, Conraads VM, Timmermans JP, Vrints CJ (2010) Current perspective of pathophysiological and interventional effects on endothelial progenitor cell biology: focus on PI3K/AKT/eNOS pathway. Int J Cardiol 144:350–366PubMedCrossRef
41.
go back to reference Seeger FH, Haendeler J, Walter DH, Rochwalsky U, Reinhold J, Urbich C, Rossig L, Corbaz A, Chvatchko Y, Zeiher AM, Dimmeler S (2005) p38 mitogen-activated protein kinase downregulates endothelial progenitor cells. Circulation 111:1184–1191PubMedCrossRef Seeger FH, Haendeler J, Walter DH, Rochwalsky U, Reinhold J, Urbich C, Rossig L, Corbaz A, Chvatchko Y, Zeiher AM, Dimmeler S (2005) p38 mitogen-activated protein kinase downregulates endothelial progenitor cells. Circulation 111:1184–1191PubMedCrossRef
42.
go back to reference Wu Y, Wang Q, Cheng L, Wang J, Lu G (2009) Effect of oxidized low-density lipoprotein on survival and function of endothelial progenitor cell mediated by p38 signal pathway. J Cardiovasc Pharmacol 53:151–156PubMedCrossRef Wu Y, Wang Q, Cheng L, Wang J, Lu G (2009) Effect of oxidized low-density lipoprotein on survival and function of endothelial progenitor cell mediated by p38 signal pathway. J Cardiovasc Pharmacol 53:151–156PubMedCrossRef
43.
go back to reference Kuki S, Imanishi T, Kobayashi K, Matsuo Y, Obana M, Akasaka T (2006) Hyperglycemia accelerated endothelial progenitor cell senescence via the activation of p38 mitogen-activated protein kinase. Circ J 70:1076–1081PubMedCrossRef Kuki S, Imanishi T, Kobayashi K, Matsuo Y, Obana M, Akasaka T (2006) Hyperglycemia accelerated endothelial progenitor cell senescence via the activation of p38 mitogen-activated protein kinase. Circ J 70:1076–1081PubMedCrossRef
44.
go back to reference Huh JE, Nam DW, Baek YH, Kang JW, Park DS, Choi DY, Lee JD (2011) Formononetin accelerates wound repair by the regulation of early growth response factor-1 transcription factor through the phosphorylation of the ERK and p38 MAPK pathways. Int Immunopharmacol 11:46–54PubMedCrossRef Huh JE, Nam DW, Baek YH, Kang JW, Park DS, Choi DY, Lee JD (2011) Formononetin accelerates wound repair by the regulation of early growth response factor-1 transcription factor through the phosphorylation of the ERK and p38 MAPK pathways. Int Immunopharmacol 11:46–54PubMedCrossRef
45.
go back to reference Sieveking DP, Buckle A, Celermajer DS, Ng MK (2008) Strikingly different angiogenic properties of endothelial progenitor cell subpopulations: insights from a novel human angiogenesis assay. J Am Coll Cardiol 51:660–668PubMedCrossRef Sieveking DP, Buckle A, Celermajer DS, Ng MK (2008) Strikingly different angiogenic properties of endothelial progenitor cell subpopulations: insights from a novel human angiogenesis assay. J Am Coll Cardiol 51:660–668PubMedCrossRef
46.
go back to reference Bouvard C, Gafsou B, Dizier B, Galy-Fauroux I, Lokajczyk A, Boisson-Vidal C, Fischer AM, Helley D (2010) Alpha6-integrin subunit plays a major role in the proangiogenic properties of endothelial progenitor cells. Arterioscler Thromb Vasc Biol 30:1569–1575PubMedCrossRef Bouvard C, Gafsou B, Dizier B, Galy-Fauroux I, Lokajczyk A, Boisson-Vidal C, Fischer AM, Helley D (2010) Alpha6-integrin subunit plays a major role in the proangiogenic properties of endothelial progenitor cells. Arterioscler Thromb Vasc Biol 30:1569–1575PubMedCrossRef
Metadata
Title
Acidic preconditioning improves the proangiogenic responses of endothelial colony forming cells
Authors
Hebe A. Mena
Anna Lokajczyk
Blandine Dizier
Sergio E. Strier
Liliana S. Voto
Catherine Boisson-Vidal
Mirta Schattner
Soledad Negrotto
Publication date
01-10-2014
Publisher
Springer Netherlands
Published in
Angiogenesis / Issue 4/2014
Print ISSN: 0969-6970
Electronic ISSN: 1573-7209
DOI
https://doi.org/10.1007/s10456-014-9434-5

Other articles of this Issue 4/2014

Angiogenesis 4/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine